| ￥3000 | |
| Z05063-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Human NKp30, hFc Tag captured on CM5 Chip via Protein A can bind B7-H6/NCR3LG1, His, Human in SPR assay (Biacore T200). Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 27.8 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 50-68 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
The purity of B7-H6/NCR3LG1, His, Human is greater than 95% as determined by SEC-HPLC. »
B7-H6/NCR3LG1, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Human NKp30, hFc Tag captured on CM5 Chip via Protein A can bind B7-H6/NCR3LG1, His, Human, His Tag with an affinity constant of 48.67 nM as determined in SPR assay (Biacore T200) (QC Test). »
| Target Background | B7-H6 is a glycosylated member of the B7 family of immune co‑stimulatory proteins. which is a ligand for the NK cell activating receptor NKp30, was targeted to create a CAR that targets multiple tumor types. B7H6 is expressed on various primary human tumors, including leukemia, lymphoma and gastrointestinal stromal tumors, but it is not constitutively expressed on normal tissues. |
| Synonyms | B7H6; B7-H6; DKFZp686I21167; DKFZp686O24166; NCR3LG1; B7 Homolog 6 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
